The role of selective serotonin reuptake inhibitors in reducing alcohol consumption

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 20, 2001, Pages 18-25

  Naranjo, C A ^a   Knoke, D M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALCOHOL; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VIQUALINE; ZIMELDINE;

ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE MODEL; DRINKING BEHAVIOR; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GENDER; HUMAN; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; TREATMENT PLANNING;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CITALOPRAM; CLINICAL TRIALS; COMORBIDITY; DRINKING BEHAVIOR; DRUG EVALUATION, PRECLINICAL; FLUOXETINE; FLUVOXAMINE; HUMANS; MICE; RATS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0034809247     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis
2. Drugs of abuse: Anatomy, pharmacology and function of reward pathways
3. Drug abuse: Hedonic homeostatic dysregulation
4. Alcohol and the brain: Pharmacological insights for psychiatrists
5. Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies
6. Pharmacogenetic models of alcoholism
7. Evaluation of the effects of serotonin uptake inhibitors in alcoholics: A review
8. Identification and testing of new drugs for modulating alcohol consumption
9. Effects of citalopram and a brief psychosocial intervention on alcohol intake, dependence and problems
10. Naltrexone and coping skills therapy for alcohol dependence: A controlled study
11. Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence
12. 5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions
13. Platelet serotonin levels in alcoholic patients: Changes related to physiological and pathological factors
14. Age of alcoholism onset, 2: Relationship to susceptibility to serotonin precursor availability
15. Serotonergic and noradrenergic dysregulation in alcoholism: m-Chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects
16. Neuroendocrine responses to serotonergic agents in alcoholics
17. Effect of citalopram on alcohol intake in heavy drinkers
18. Trait markers for alcoholism: Clinical utility
19. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
20. Effect of fluoxetine on alcohol consumption in male alcoholics
21. Fluoxetine attenuates alcohol intake and desire to drink
22. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
23. The serotonin uptake inhibitor citalopram attenuates ethanol intake
24. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers
25. Citalopram in the treatment of alcoholism: A double-blind placebo-controlled study
26. Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics
27. The pharmacology of citalopram
28. A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: Adjunctive pharmacotherapy during and after inpatient treatment
29. Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism
30. Pharmacologic treatments for drug and alcohol dependence
31. Using fuzzy logic to predict response to citalopram in alcohol dependence
32. Variations in response to citalopram in alcohol-dependent males and females
33. Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking
34. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics
35. Types of alcoholics, 1: Evidence for an empirically derived typology based on indicators of vulnerability and severity
36. Sertraline treatment for alcohol dependence: Interactive effects of medication and subtype
37. Neurogenetic adaptive mechanisms in alcoholism
38. Reduced central serotonin turnover in a subgroup of alcoholics?
39. Personality profiles and state aggressiveness in Finnish alcoholics, violent offenders, fire setters, and healthy volunteers
40. Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics
41. Reduced central serotonin transporters in alcoholism
42. Platelet serotonergic binding sites in alcohol-dependent patients
43. Serotonin and alcohol intake, abuse, and dependence: Clinical evidence
44. Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial
45. Preliminary report: Double-blind, placebo-controlled study of fluoxetine in depressed alcoholics
46. Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers
47. Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers
48. Weight loss induced by serotonin uptake inhibitors (SUI) in male heavy drinkers
49. Differential effects of viqualine on alcohol intake and other consummatory behaviors
50. Naltrexone, relapse prevention, and supportive therapy with alcoholics: An analysis of patient treatment matching
51. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence
52. Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior
53. Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence?